Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$422.78 USD
+3.79 (0.90%)
Updated May 10, 2024 04:00 PM ET
After-Market: $422.80 +0.02 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | 4.11 |
EPS Last Quarter | 4.76 |
Last EPS Surprise | 16.10% |
ABR | 1.87 |
Earnings ESP
|
1.32% |
---|---|
Current Year | 16.77 |
Next Year | 17.85 |
EPS (TTM) | 16.93 |
P/E (F1) | 25.20 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.63B | 2.68B | 10.72B | 11.60B |
# of Estimates | 11 | 11 | 12 | 12 |
High Estimate | 2.70B | 2.72B | 10.83B | 13.12B |
Low Estimate | 2.55B | 2.64B | 10.64B | 11.17B |
Year ago Sales | 2.49B | 2.48B | 9.87B | 10.72B |
Year over Year Growth Est. | 5.49% | 7.81% | 8.58% | 8.25% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.11 | 4.11 | 16.77 | 17.85 |
# of Estimates | 12 | 10 | 14 | 13 |
Most Recent Consensus | 4.24 | 4.11 | 17.03 | 17.03 |
High Estimate | 4.37 | 4.42 | 17.77 | 20.54 |
Low Estimate | 3.77 | 3.75 | 15.15 | 14.58 |
Year ago EPS | 3.89 | 4.08 | 15.23 | 16.77 |
Year over Year Growth Est. | 5.66% | 0.74% | 10.11% | 6.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 0 |
Up Last 30 Days | 2 | 0 | 3 | 0 |
Up Last 60 Days | 2 | 0 | 3 | 0 |
Down Last 7 Days | 0 | 0 | 2 | 2 |
Down Last 30 Days | 0 | 1 | 2 | 6 |
Down Last 60 Days | 0 | 2 | 2 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.11 | 4.11 | 16.77 | 17.85 |
7 Days Ago | 4.06 | 4.11 | 16.76 | 18.00 |
30 Days Ago | 4.04 | 4.12 | 16.79 | 18.20 |
60 Days Ago | 4.04 | 4.12 | 16.79 | 18.19 |
90 Days Ago | 4.05 | 4.12 | 16.79 | 18.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 4.16 | 3.96 | 16.73 | 17.24 |
Zacks Consensus Estimate | 4.11 | 4.11 | 16.77 | 17.85 |
Earnings ESP | 1.32% | -3.71% | -0.26% | -3.41% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 4.76 | 4.20 | 4.08 | 3.89 | NA |
Estimate | 4.10 | 4.10 | 3.92 | 3.85 | NA |
Difference | 0.66 | 0.10 | 0.16 | 0.04 | 0.24 |
Surprise | 16.10% | 2.44% | 4.08% | 1.04% | 5.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more